Home › AI in mental health
National Guidance for AI in Mental Health and Substance Use Health Care
Overview
The Mental Health Commission of Canada (the Commission) and the Canadian Centre on Substance Use and Addiction (CCSA) are leading the development of Canada’s first national guidance for the use of artificial intelligence (AI) to support mental health and substance use health (MHSUH).
AI is increasingly being used for healthcare triage, service navigation, service delivery, and communication, but service providers, developers and users have no guidelines specific to mental or substance use health to support its effective and safe use. The recently published E-Mental Health Strategy for Canada highlights the need for safety in this field.
National polling conducted by the Commission and Mental Health Research Canada (n = 3,519) in February 2026 highlights a significant gap between AI innovation and public confidence.
Sign up for updates on this project
These findings reinforce the importance of human oversight, transparency, accountability, and meaningful consent in building public trust in AI-enabled MHSUH care.
This multi-year initiative responds to a clear and urgent need for practical, ethical, and system-informed direction to support the safe, effective, and equitable use of AI in care delivery. A multi-phase mixed methods approach is being used to synthesize existing evidence and gather new data by consulting with a diverse range of experts in multiple sectors.
A national steering committee provides strategic oversight and expert advice. The committee includes individuals with expertise in clinical practice, policy, AI, ethics, data governance, and lived and living experience, including First Nations, Métis, and Inuit perspectives. It guides project priorities and ensures diverse perspectives are integrated, and members of the committee champion uptake through their networks.
The steering committee is complemented by a multidisciplinary health-care professionals advisory group representing a broad range of front-line disciplines (e.g., physicians, nurses, psychologists, social workers, peer support workers, and community practitioners). Acting in a consultative capacity, the group provides practice-informed input to ensure the guidance is relevant, feasible, and grounded in real-world care and implementation contexts.
The current phase of work represents a critical shift from conceptual considerations to the development of actionable guidance, implementation-oriented criteria, and practical resources to support adoption across the MHSUH ecosystem.
What we learned
Findings from an environmental scan, literature review, and consultations with clinicians, researchers, policy makers, digital and AI tool developers, and people with lived and living experience reinforced three core themes related to the use of AI to support MHSUH.
From transparency to usable clarity
It is important to ensure that AI tools can be understood, evaluated, and used responsibly in practice. The focus must shift toward practical clarity to help users make relevant decisions. Practitioners require sufficient AI literacy to understand when and how tools should be used responsibly and to have confidence in the reliability of the tools’ outputs.
Preserving the therapeutic relationship
AI should enhance care without disrupting the therapeutic relationship. Human-centred care must remain foundational, with AI supporting rather than replacing human connection, empathy, and clinical judgment.
Addressing structural risk
Fairness, inclusion, privacy, and responsible data use must be promoted while recognizing and preparing for inevitable risks.
The Commission and CCSA developed a short resource highlighting the work to date, key insights, and next steps.
Steering Committee Members
The Steering Committee provides strategic advice and oversight, ensuring that diverse perspectives, including lived and living experience, First Nations, Métis and Inuit perspectives, ethics, equity, legal, and technical expertise, are integrated into the guidance.
View Members
Dr. Aislin R. Mushquash
Associate Professor; Lakehead University Research Chair in Youth Mental Health; Clinical Psychologist, Lakehead University
Al Raimundo
- Person with lived experience/Technical experience
Dr. Allison Crawford, MD, PhD
Chief Medical Officer, 9-8-8 Suicide Crisis Helpline
Professor Departments of Psychiatry and Dalla Lana School of Public Health, University of Toronto
Psychiatrist, Centre for Addiction and Mental Health
Anthony Esposti
CEO, CAPSA
Ashley Silversides
- Treatment Manager
Mamisarvik Healing Centre
Carly Straker
Manager, System Quality and Integration, Mental Wellness and Addictions Recovery Division, Government of the Northwest Territories
Chris Cull
Strategic and Technical Advisory Group on Mental Health, Neurological and Substance Use Conditions
World Health Organization
Dr. Christopher DiCarlo
Principal/Founder, Critical Thinking Solutions
Dr. Christopher Mushquash
Dr. David Martell
Physician Lead, Addiction Medicine – Mental Health & Addictions Program, Nova Scotia Health
Dr. David Wiljer, PhD
Associate Dean, CPD, Temerty Faculty of Medicine;
Professor (status only), Department of Psychiatry and IHPME,
University of Toronto; Scientist, The Wilson Centre;
Executive Director, Education Technology Innovation,
University Health Network.
Jason Miller
Jeannie Borg RN, MA Leadership
Director of Clinical Informatics and Digital Health, Waypoint Centre for Mental Health Care
Jennifer Dahak
Jonathan Morris
CEO, Canadian Mental Health Association BC Division
Kim Kulbacki
Dr. Leslie E. Roos
Associate Professor, Departments of Psychology & Pediatrics; Licensed Clinical Psychologist; Clinical Scientist at Children’s Hospital Research Institute of Manitoba; CIHR Implementation Science Chair in Human Development, Child, and Youth Health
The University of Manitoba
Norm Odjick
Director General, Algonquin Anishinaabeg Nation Tribal Council
Rebecca Jesseman
Executive Director, Mental Health and Addictions, Health PEI
Russell Greiner
Professor, Department of Computing Science, University of Alberta
Adjunct Professor, Department of Psychiatry, University of Alberta
Canada CIFAR AI Chair and Fellow-in-Residence, Alberta Machine Intelligence Institute (Amii)
Stephanie Thevarajah
Valerie Pisano
President & CEO, MILA
Health Care Professional Advisory Group
The Health Care Professional Advisory Group provides clinical and practice-informed input, expertise, and advice focused on implementation realities, professional considerations, and frontline care contexts.
View Members
Dr. Conrad Sichler
Medical Psychotherapy Association of Canada
Dr. Devin Fowlie
- Canadian Psychological Association
Dr. Erin Knight
Canadian Society of Addiction Medicine
Florence Budden
Canadian Federation of Mental Health Nurses
Dr. Hance Clarke
- Canadian Pain Society
Karina Albert
Canadian Counselling and Psychotherapy Association
Dr. Leyna Lowe
Canadian Mental Health Association
Lisa Diamond-Burchuk
- Canadian Association of Occupational Therapists
Mayce Al-Sukhni
Canadian Society of Healthcare Systems Pharmacy Representative
Dr. Norm Buckley
McMaster University/Institute for Pain Research and Care
Dr. Sarah Pennisi
Canadian Association of Social Workers
Tifaine Magnusson
Canadian Society of Healthcare Systems Pharmacy Representative
Tracie Risling
Canadian Nurses Association
Dr. Vijay Seethapathy
Canadian Psychiatric Association